119 related articles for article (PubMed ID: 8771563)
1. L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies.
Xu XJ; Hoffmann O; Wiesenfeld-Hallin Z
Neuropeptides; 1996 Apr; 30(2):203-6. PubMed ID: 8771563
[TBL] [Abstract][Full Text] [Related]
2. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
Rezayat M; Oreizi S; Zarrindast MR
Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
[TBL] [Abstract][Full Text] [Related]
3. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
Friedrich AE; Gebhart GF
J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
Sullivan AF; Hewett K; Dickenson AH
Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
[TBL] [Abstract][Full Text] [Related]
5. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
6. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
7. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
Zhou Y; Sun YH; Zhang ZW; Han JS
Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
Legido A; Adler MW; Karkanias C; Geller EB; Bradley E; Greenstein JI; Grover WD
Neuropeptides; 1995 Feb; 28(2):107-13. PubMed ID: 7746354
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
[TBL] [Abstract][Full Text] [Related]
10. [Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
Zhou Y; Sun YH; Han JS
Sheng Li Xue Bao; 1993 Jun; 45(3):255-61. PubMed ID: 8235725
[TBL] [Abstract][Full Text] [Related]
11. Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes.
Hawranko AA; Smith DJ
Brain Res; 1999 Apr; 824(2):251-7. PubMed ID: 10196456
[TBL] [Abstract][Full Text] [Related]
12. The enhancement of morphine antinociception by a CCKB receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesia.
Perrot S; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Pain; 1998 Feb; 74(2-3):269-74. PubMed ID: 9520241
[TBL] [Abstract][Full Text] [Related]
13. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
14. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
Lavigne GJ; Millington WR; Mueller GP
Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
[TBL] [Abstract][Full Text] [Related]
15. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
[TBL] [Abstract][Full Text] [Related]
16. CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level.
Xu XJ; Elfvin A; Hao JX; Fournié-Zaluski MC; Roques BP; Wiesenfeld-Hallin Z
Neuropeptides; 1997 Jun; 31(3):287-91. PubMed ID: 9243527
[TBL] [Abstract][Full Text] [Related]
17. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.
Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F
Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
19. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
20. CCK(B) receptor antagonist L365,260 potentiates the efficacy to and reverses chronic tolerance to electroacupuncture-induced analgesia in mice.
Huang C; Hu ZP; Jiang SZ; Li HT; Han JS; Wan Y
Brain Res Bull; 2007 Mar; 71(5):447-51. PubMed ID: 17259012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]